Polyneuron
is a Switzerland-based pharmaceutical company that develops and commercializes biodegradable glycopolymers for the treatment of autoimmune diseases... Read morePolyneuron
is a Switzerland-based pharmaceutical company that develops and commercializes biodegradable glycopolymers for the treatment of autoimmune diseases... Read more
News
Apr 14, 2021
BioSpace
Polyneuron: Polyneuron and University of Basel Awarded Grant of CHF 1.2M to Advance Novel Treatments to Support ABO-Incompatible Transplants
Sep 29, 2020
Global Legal Chronicle
Polyneuron: Polyneuron Pharamceuticals AG's To Extend To CHF 36.5 Million Its Series A Financing Round
Sep 23, 2020
Global University Venturing
Polyneuron: Polyneuron binds in extra series A cash - Global University Venturing
Sep 22, 2020
FinSMEs
Polyneuron: Polyneuron Raises Additional CHF 14M; Expands Series A to CHF 36.5M
Sep 17, 2020
European Biotechnology
Polyneuron: Polyneuron Pharmaceuticals AG extends Series A financing
Jun 05, 2020
Picante Today
Polyneuron: Polyneuron's PN-1007 Receives U.S. FDA Orphan Drug Designation in Anti-MAG Neuropathy
Jun 05, 2020
firstwordpharma
Polyneuron: Polyneuron's PN-1007 Receives U.S. FDA Orphan Drug Designation in Anti-MAG Neuropathy
Apr 27, 2020
MarketScreener
Polyneuron: Polyneuron Receives Approval to Begin Clinical Study With PN-1007 in Anti-MAG Neuropathy
Apr 07, 2020
startupticker
Polyneuron: Polyneuron submits clinical trial application
Mar 28, 2019
PE Hub Network
Polyneuron: Swiss biotech company Polyneuron inks funding
Polyneuron Competitors
1
2
3
4
5
6
7
8
9
10